Which complications should the nurse monitor for in a client prescribed valproic acid?

Get ready for the NCLEX Exam! Practice with our comprehensive quizzes and multiple choice questions. Each question offers detailed explanations to help you understand the material and improve your test-taking skills. Boost your confidence today!

Multiple Choice

Which complications should the nurse monitor for in a client prescribed valproic acid?

Valproic acid, often used as an anticonvulsant and mood stabilizer, carries certain risks that necessitate careful monitoring. The client prescribed valproic acid should be monitored for both pancreatitis and hepatotoxicity, making this option the correct choice. Pancreatitis is a serious inflammatory condition of the pancreas that has been associated with the use of valproic acid. Symptoms can include severe abdominal pain, nausea, vomiting, and elevated pancreatic enzymes. As such, healthcare providers need to be vigilant for signs of gastrointestinal distress that could indicate this complication. Hepatotoxicity is another serious concern associated with valproic acid, especially in certain populations such as young children or those with preexisting liver disease. Signs of liver damage can manifest as jaundice, elevated liver enzymes, fatigue, and abdominal pain. Regular monitoring of liver function tests is critical in clients taking this medication to mitigate the risk of significant liver injury. The combination of monitoring for both pancreatitis and hepatotoxicity reflects a comprehensive approach to patient safety with valproic acid therapy. This highlights the importance of assessing a client's clinical status and laboratory values while they are on this medication to prevent and identify serious complications timely.

Valproic acid, often used as an anticonvulsant and mood stabilizer, carries certain risks that necessitate careful monitoring. The client prescribed valproic acid should be monitored for both pancreatitis and hepatotoxicity, making this option the correct choice.

Pancreatitis is a serious inflammatory condition of the pancreas that has been associated with the use of valproic acid. Symptoms can include severe abdominal pain, nausea, vomiting, and elevated pancreatic enzymes. As such, healthcare providers need to be vigilant for signs of gastrointestinal distress that could indicate this complication.

Hepatotoxicity is another serious concern associated with valproic acid, especially in certain populations such as young children or those with preexisting liver disease. Signs of liver damage can manifest as jaundice, elevated liver enzymes, fatigue, and abdominal pain. Regular monitoring of liver function tests is critical in clients taking this medication to mitigate the risk of significant liver injury.

The combination of monitoring for both pancreatitis and hepatotoxicity reflects a comprehensive approach to patient safety with valproic acid therapy. This highlights the importance of assessing a client's clinical status and laboratory values while they are on this medication to prevent and identify serious complications timely.

More practice questions